United States

People: OncoMed Pharmaceuticals Inc (OMED.OQ)

OMED.OQ on NASDAQ Stock Exchange Global Select Market

22 Feb 2019
Change (% chg)

$0.02 (+2.76%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Gurney, Austin 

Dr. Austin Gurney Ph.D. is Senior Vice President, Molecular and Cellular Biology of the company. Previously served as our Vice President of Molecular and Cellular Biology from 2004. Prior to that time, Dr. Gurney worked at Genentech, Inc., where his research contributed to the discovery of numerous growth factors and cytokines. Dr. Gurney has authored or co-authored more than 60 published scientific papers and is listed as an inventor on over 600 patents related to therapeutic applications in immunology and cancer. Dr. Gurney received a B.S. in Biology from Rensselaer Polytechnic Institute and a Ph.D.in Molecular and Cellular Biology from the Case Western Reserve University School of Medicine.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Awards, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --